(a) whether the Super Bazar has been selling inferior medicines and not those of
multinationals;
(b) if so, the steps taken to sell medicines only from MNCs as has been done by the Kendriya Bhandar;
(c) whether any investigation in connection with procurement of medicines on inflated prices was conducted by the Vigilance Department of Super Bazar;
(d) if so, whether the proceedings have been concluded;
(e) if so, the details thereof and the action taken against the officials; and
(f) if not, the reasons for delay in concluding the proceedings?